title: Diabetic vascular hypertrophy and albuminuria: effect of angiotensin converting enzyme inhibition.
abstract: The role of angiotensin-converting enzyme (ACE) inhibition with ramipril on mesenteric vascular hypertrophy and urinary albumin excretion was explored in a normotensive model of experimental diabetes. Serial measurements of albuminuria were performed in Sprague-Dawley control, diabetic rats, and diabetic rats treated with ramipril. Over 24 weeks, urinary albumin excretion showed a continuous rise in the untreated diabetic rats. Ramipril prevented the increase in albuminuria over the whole study period. After 6 months, animals were perfused with glutaraldehyde and sacrificed for measurement of mesenteric vessel wall/lumen ratio and kidney weight. Diabetes was associated with increased mesenteric wall/lumen ratio and kidney weight. ACE inhibition, despite no effect on glycemic control, attenuated mesenteric vascular hypertrophy but did not decrease kidney weight. In addition to the well-described renoprotective effects of ACE inhibition in diabetes, this class of agents may have a favorable effect on diabetic vascular disease.
authors.affiliation: Department of Medicine, University of Melbourne, Austin, Australia.
authors.forename: T J
authors.initials: TJ
authors.lastname: Allen
authors.forename: U L
authors.initials: UL
authors.lastname: Hulthen
authors.forename: J R
authors.initials: JR
authors.lastname: Rumble
authors.forename: M
authors.initials: M
authors.lastname: Jasik
authors.forename: M E
authors.initials: ME
authors.lastname: Cooper
mesh_terms: D000419:Albuminuria / Q000517:prevention & control*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D001835:Body Weight / Q000187:drug effects; D003921:Diabetes Mellitus, Experimental / Q000473:pathology / Q000503:physiopathology*; D003928:Diabetic Nephropathies / Q000517:prevention & control; D006442:Glycated Hemoglobin / Q000032:analysis; D006984:Hypertrophy; D007668:Kidney / Q000187:drug effects; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000473:pathology; D009929:Organ Size / Q000187:drug effects; D017257:Ramipril / Q000627:therapeutic use*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012016:Reference Values; D012083:Renin / Q000097:blood; D013152:Splanchnic Circulation / Q000187:drug effects*; D013599:Systole / Q000187:drug effects
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D001786:Blood Glucose; D006442:Glycated Hemoglobin; D017257:Ramipril; D012083:Renin